<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>National Natural Science Foundation of China</funding><pagination>2971413</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5603109</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2017</volume><pubmed_abstract>With the emerging role of umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) for bone regeneration and delivery of therapeutic proteins, there is an increasing need for effective gene delivery systems to modify such cells. mTAT, a TAT peptide sequence bearing histidine and cysteine residues, has been successfully used for intracellular gene delivery. Using a gWiz-GFP plasmid, we demonstrated that polyethylenimine combined with mTAT (mTAT/PEI) displayed good transfection efficacy in hUCB-MSC. hUCB-MSC transfected with mTAT/PEI were shown to express more BMP-2 protein and mRNA, indicating the feasibility of using the cells as a BMP-2 delivery system. Importantly, compared to PEI25, a "gold standard" nonviral transfection polymer, mTAT/PEI had limited toxicity to the cells. Furthe</pubmed_abstract><journal>BioMed research international</journal><pubmed_title>Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Combined with Modified TAT Peptide to Enhance BMP-2 Production.</pubmed_title><pmcid>PMC5603109</pmcid><funding_grant_id>2017-325</funding_grant_id><funding_grant_id>2015M541484</funding_grant_id><funding_grant_id>LBH-Z14147</funding_grant_id><funding_grant_id>81401342</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Yan J</pubmed_authors><pubmed_authors>Wei R</pubmed_authors><pubmed_authors>You C</pubmed_authors><pubmed_authors>Song C</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zu J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Combined with Modified TAT Peptide to Enhance BMP-2 Production.</name><description>With the emerging role of umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) for bone regeneration and delivery of therapeutic proteins, there is an increasing need for effective gene delivery systems to modify such cells. mTAT, a TAT peptide sequence bearing histidine and cysteine residues, has been successfully used for intracellular gene delivery. Using a gWiz-GFP plasmid, we demonstrated that polyethylenimine combined with mTAT (mTAT/PEI) displayed good transfection efficacy in hUCB-MSC. hUCB-MSC transfected with mTAT/PEI were shown to express more BMP-2 protein and mRNA, indicating the feasibility of using the cells as a BMP-2 delivery system. Importantly, compared to PEI25, a "gold standard" nonviral transfection polymer, mTAT/PEI had limited toxicity to the cells. Furthe</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-04-05T14:31:20.115Z</modification><creation>2019-03-27T02:56:40Z</creation></dates><accession>S-EPMC5603109</accession><cross_references><pubmed>28951869</pubmed><doi>10.1155/2017/2971413</doi></cross_references></HashMap>